TY - JOUR AU - Pollyea, D. A. AU - Kohrt, H. E. AU - Medeiros, B. C. PY - 2011 DA - 2011// TI - Acute myeloid leukaemia in the elderly: a review JO - Br J Haematol VL - 152 UR - https://doi.org/10.1111/j.1365-2141.2010.08470.x DO - 10.1111/j.1365-2141.2010.08470.x ID - Pollyea2011 ER - TY - JOUR AU - Pulte, D. AU - Gondos, A. AU - Brenner, H. PY - 2010 DA - 2010// TI - Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006-2010 JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO VL - 21 UR - https://doi.org/10.1093/annonc/mdp309 DO - 10.1093/annonc/mdp309 ID - Pulte2010 ER - TY - JOUR AU - van Rhenen, A. AU - Feller, N. AU - Kelder, A. AU - Westra, A. H. AU - Rombouts, E. AU - Zweegman, S. AU - van der Pol, M. A. AU - Waisfisz, Q. AU - Ossenkoppele, G. J. AU - Schuurhuis, G. J. PY - 2005 DA - 2005// TI - High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival JO - Clinical cancer research : an official journal of the American Association for Cancer Research VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-05-0468 DO - 10.1158/1078-0432.CCR-05-0468 ID - van Rhenen2005 ER - TY - JOUR AU - Lowenberg, B. AU - Ossenkoppele, G. J. AU - van Putten, W. AU - Schouten, H. C. AU - Graux, C. AU - Ferrant, A. AU - Sonneveld, P. AU - Maertens, J. AU - Jongen-Lavrencic, M. AU - von Lilienfeld-Toal, M. PY - 2009 DA - 2009// TI - High-dose daunorubicin in older patients with acute myeloid leukemia JO - N Engl J Med VL - 361 UR - https://doi.org/10.1056/NEJMoa0901409 DO - 10.1056/NEJMoa0901409 ID - Lowenberg2009 ER - TY - JOUR AU - Kottaridis, P. D. AU - Gale, R. E. AU - Frew, M. E. AU - Harrison, G. AU - Langabeer, S. E. AU - Belton, A. A. AU - Walker, H. AU - Wheatley, K. AU - Bowen, D. T. AU - Burnett, A. K. PY - 2001 DA - 2001// TI - The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12 trials JO - Blood VL - 98 UR - https://doi.org/10.1182/blood.V98.6.1752 DO - 10.1182/blood.V98.6.1752 ID - Kottaridis2001 ER - TY - JOUR AU - Byrd, J. C. AU - Mrozek, K. AU - Dodge, R. K. AU - Carroll, A. J. AU - Edwards, C. G. AU - Arthur, D. C. AU - Pettenati, M. J. AU - Patil, S. R. AU - Rao, K. W. AU - Watson, M. S. PY - 2002 DA - 2002// TI - Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and leukemia group B (CALGB 8461) JO - Blood VL - 100 UR - https://doi.org/10.1182/blood-2002-03-0772 DO - 10.1182/blood-2002-03-0772 ID - Byrd2002 ER - TY - JOUR AU - Fopp, M. AU - Fey, M. F. AU - Bacchi, M. AU - Cavalli, F. AU - Gmuer, J. AU - Jacky, E. AU - Schmid, L. AU - Tichelli, A. AU - Tobler, A. AU - Tschopp, L. PY - 1997 DA - 1997// TI - Post-remission therapy of adult acute myeloid leukaemia: one cycle of high-dose versus standard-dose cytarabine. Leukaemia project Group of the Swiss Group for clinical Cancer research (SAKK) JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO VL - 8 UR - https://doi.org/10.1023/A:1008267904952 DO - 10.1023/A:1008267904952 ID - Fopp1997 ER - TY - JOUR AU - Lowenberg, B. AU - Pabst, T. AU - Vellenga, E. AU - van Putten, W. AU - Schouten, H. C. AU - Graux, C. AU - Ferrant, A. AU - Sonneveld, P. AU - Biemond, B. J. AU - Gratwohl, A. PY - 2011 DA - 2011// TI - Cytarabine dose for acute myeloid leukemia JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1010222 DO - 10.1056/NEJMoa1010222 ID - Lowenberg2011 ER - TY - JOUR AU - Creutzig, U. AU - Zimmermann, M. AU - Ritter, J. AU - Reinhardt, D. AU - Hermann, J. AU - Henze, G. AU - Jurgens, H. AU - Kabisch, H. AU - Reiter, A. AU - Riehm, H. PY - 2005 DA - 2005// TI - Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials JO - Leukemia VL - 19 UR - https://doi.org/10.1038/sj.leu.2403920 DO - 10.1038/sj.leu.2403920 ID - Creutzig2005 ER - TY - JOUR AU - Kadia, T. M. AU - Ravandi, F. AU - Cortes, J. AU - Kantarjian, H. PY - 2016 DA - 2016// TI - New drugs in acute myeloid leukemia JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO VL - 27 UR - https://doi.org/10.1093/annonc/mdw015 DO - 10.1093/annonc/mdw015 ID - Kadia2016 ER - TY - STD TI - Saultz JN, Garzon R. Acute myeloid leukemia: a concise review. Journal of clinical medicine. 2016;5(3):33. ID - ref11 ER - TY - JOUR AU - Kolb, H. J. AU - Schattenberg, A. AU - Goldman, J. M. AU - Hertenstein, B. AU - Jacobsen, N. AU - Arcese, W. AU - Ljungman, P. AU - Ferrant, A. AU - Verdonck, L. AU - Niederwieser, D. PY - 1995 DA - 1995// TI - Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients JO - Blood VL - 86 ID - Kolb1995 ER - TY - JOUR AU - Yanada, M. AU - Matsuo, K. AU - Emi, N. AU - Naoe, T. PY - 2005 DA - 2005// TI - Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis JO - Cancer VL - 103 UR - https://doi.org/10.1002/cncr.20945 DO - 10.1002/cncr.20945 ID - Yanada2005 ER - TY - JOUR AU - Huang, X. J. AU - Liu, D. H. AU - Liu, K. Y. AU - Xu, L. P. AU - Chen, H. AU - Han, W. AU - Chen, Y. H. AU - Zhang, X. H. AU - Lu, D. P. PY - 2009 DA - 2009// TI - Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation JO - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation VL - 15 UR - https://doi.org/10.1016/j.bbmt.2008.11.025 DO - 10.1016/j.bbmt.2008.11.025 ID - Huang2009 ER - TY - JOUR AU - Bleakley, M. AU - Riddell, S. R. PY - 2004 DA - 2004// TI - Molecules and mechanisms of the graft-versus-leukaemia effect JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1365 DO - 10.1038/nrc1365 ID - Bleakley2004 ER - TY - JOUR AU - Zhang, Z. X. AU - Yang, L. AU - Young, K. J. AU - DuTemple, B. AU - Zhang, L. PY - 2000 DA - 2000// TI - Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression JO - Nat Med VL - 6 UR - https://doi.org/10.1038/77513 DO - 10.1038/77513 ID - Zhang2000 ER - TY - JOUR AU - Merims, S. AU - Li, X. AU - Joe, B. AU - Dokouhaki, P. AU - Han, M. AU - Childs, R. W. AU - Wang, Z. Y. AU - Gupta, V. AU - Minden, M. D. AU - Zhang, L. PY - 2011 DA - 2011// TI - Anti-leukemia effect of ex vivo expanded DNT cells from AML patients: a potential novel autologous T-cell adoptive immunotherapy JO - Leukemia VL - 25 UR - https://doi.org/10.1038/leu.2011.99 DO - 10.1038/leu.2011.99 ID - Merims2011 ER - TY - STD TI - Lee JB, Minden MD, Chen WC, Streck E, Chen B, Kang H, Arruda A, Ly D, Der SD KS, et al. Allogeneic human double negative T cells as a novel immunotherapy for acute myeloid leukemia and its underlying mechanisms. Clinical cancer research : an official journal of the American Association for Cancer Research. 2017;24(2):370–382 ID - ref18 ER - TY - JOUR AU - Zitvogel, L. AU - Apetoh, L. AU - Ghiringhelli, F. AU - Kroemer, G. PY - 2008 DA - 2008// TI - Immunological aspects of cancer chemotherapy JO - Nat Rev Immunol VL - 8 UR - https://doi.org/10.1038/nri2216 DO - 10.1038/nri2216 ID - Zitvogel2008 ER - TY - JOUR AU - Galetto, A. AU - Buttiglieri, S. AU - Forno, S. AU - Moro, F. AU - Mussa, A. AU - Matera, L. PY - 2003 DA - 2003// TI - Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells JO - Anti-Cancer Drugs VL - 14 UR - https://doi.org/10.1097/00001813-200311000-00010 DO - 10.1097/00001813-200311000-00010 ID - Galetto2003 ER - TY - JOUR AU - Apetoh, L. AU - Ghiringhelli, F. AU - Tesniere, A. AU - Obeid, M. AU - Ortiz, C. AU - Criollo, A. AU - Mignot, G. AU - Maiuri, M. C. AU - Ullrich, E. AU - Saulnier, P. PY - 2007 DA - 2007// TI - Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy JO - Nat Med VL - 13 UR - https://doi.org/10.1038/nm1622 DO - 10.1038/nm1622 ID - Apetoh2007 ER - TY - JOUR AU - Wunderlich, M. AU - Mizukawa, B. AU - Chou, F. S. AU - Sexton, C. AU - Shrestha, M. AU - Saunthararajah, Y. AU - Mulloy, J. C. PY - 2013 DA - 2013// TI - AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-10-464677 DO - 10.1182/blood-2012-10-464677 ID - Wunderlich2013 ER - TY - STD TI - Ofran Y, Rowe JM. How many cycles of 7+3 and for whom? Leukemia. 2016;30(8):1796–7 ID - ref23 ER - TY - JOUR AU - She, M. AU - Niu, X. AU - Chen, X. AU - Li, J. AU - Zhou, M. AU - He, Y. AU - Le, Y. AU - Guo, K. PY - 2012 DA - 2012// TI - Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity JO - Cancer Lett VL - 318 UR - https://doi.org/10.1016/j.canlet.2011.12.017 DO - 10.1016/j.canlet.2011.12.017 ID - She2012 ER - TY - JOUR AU - Kreis, W. AU - Chan, K. AU - Budman, D. R. AU - Schulman, P. AU - Allen, S. AU - Weiselberg, L. AU - Lichtman, S. AU - Henderson, V. AU - Freeman, J. AU - Deere, M. PY - 1988 DA - 1988// TI - Effect of tetrahydrouridine on the clinical pharmacology of 1-beta-D-arabinofuranosylcytosine when both drugs are coinfused over three hours JO - Cancer Res VL - 48 ID - Kreis1988 ER - TY - JOUR AU - Bogason, A. AU - Quartino, A. L. AU - Lafolie, P. AU - Masquelier, M. AU - Karlsson, M. O. AU - Paul, C. AU - Gruber, A. AU - Vitols, S. PY - 2011 DA - 2011// TI - Inverse relationship between leukaemic cell burden and plasma concentrations of daunorubicin in patients with acute myeloid leukaemia JO - Br J Clin Pharmacol VL - 71 UR - https://doi.org/10.1111/j.1365-2125.2010.03894.x DO - 10.1111/j.1365-2125.2010.03894.x ID - Bogason2011 ER - TY - JOUR AU - Mayer, L. D. AU - Tardi, P. G. AU - Harasym, N. L. AU - Shew, C. R. AU - Johnstone, S. A. AU - Ramsay, E. C. AU - Bally, M. B. AU - Janoff, A. S. PY - 2006 DA - 2006// TI - Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-06-0118 DO - 10.1158/1535-7163.MCT-06-0118 ID - Mayer2006 ER - TY - JOUR AU - Tardi, P. AU - Johnstone, S. AU - Harasym, N. AU - Xie, S. AU - Harasym, T. AU - Zisman, N. AU - Harvie, P. AU - Bermudes, D. AU - Mayer, L. PY - 2009 DA - 2009// TI - In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy JO - Leuk Res VL - 33 UR - https://doi.org/10.1016/j.leukres.2008.06.028 DO - 10.1016/j.leukres.2008.06.028 ID - Tardi2009 ER - TY - JOUR AU - Lapidot, T. AU - Sirard, C. AU - Vormoor, J. AU - Murdoch, B. AU - Hoang, T. AU - Caceres-Cortes, J. AU - Minden, M. AU - Paterson, B. AU - Caligiuri, M. A. AU - Dick, J. E. PY - 1994 DA - 1994// TI - A cell initiating human acute myeloid leukaemia after transplantation into SCID mice JO - Nature VL - 367 UR - https://doi.org/10.1038/367645a0 DO - 10.1038/367645a0 ID - Lapidot1994 ER - TY - JOUR AU - Sidney, L. E. AU - Branch, M. J. AU - Dunphy, S. E. AU - Dua, H. S. AU - Hopkinson, A. PY - 2014 DA - 2014// TI - Concise review: evidence for CD34 as a common marker for diverse progenitors JO - Stem Cells VL - 32 UR - https://doi.org/10.1002/stem.1661 DO - 10.1002/stem.1661 ID - Sidney2014 ER - TY - JOUR AU - van Stijn, A. AU - van der Pol, M. A. AU - Kok, A. AU - Bontje, P. M. AU - Roemen, G. M. AU - Beelen, R. H. AU - Ossenkoppele, G. J. AU - Schuurhuis, G. J. PY - 2003 DA - 2003// TI - Differences between the CD34+ and CD34- blast compartments in apoptosis resistance in acute myeloid leukemia JO - Haematologica VL - 88 ID - van Stijn2003 ER - TY - JOUR AU - Kanda, Y. AU - Hamaki, T. AU - Yamamoto, R. AU - Chizuka, A. AU - Suguro, M. AU - Matsuyama, T. AU - Takezako, N. AU - Miwa, A. AU - Kami, M. AU - Hirai, H. PY - 2000 DA - 2000// TI - The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia: an overview of 2483 patients from 22 studies JO - Cancer VL - 88 UR - https://doi.org/3.0.CO;2-S DO - 3.0.CO;2-S ID - Kanda2000 ER - TY - STD TI - Zeijlemaker W, Kelder A, Wouters R, Valk PJ, Witte BI, Cloos J, Ossenkoppele GJ, Schuurhuis GJ. Absence of leukaemic CD34(+) cells in acute myeloid leukaemia is of high prognostic value: a longstanding controversy deciphered. Br J Haematol. 2015;171(2):227–38 ID - ref33 ER - TY - JOUR AU - Nanbakhsh, A. AU - Pochon, C. AU - Mallavialle, A. AU - Amsellem, S. AU - Bourhis, J. H. AU - Chouaib, S. PY - 2014 DA - 2014// TI - C-Myc regulates expression of NKG2D ligands ULBP1/2/3 in AML and modulates their susceptibility to NK-mediated lysis JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-11-536219 DO - 10.1182/blood-2013-11-536219 ID - Nanbakhsh2014 ER - TY - JOUR AU - Soriani, A. AU - Fionda, C. AU - Ricci, B. AU - Iannitto, M. L. AU - Cippitelli, M. AU - Santoni, A. PY - 2013 DA - 2013// TI - Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma JO - Oncoimmunology VL - 2 UR - https://doi.org/10.4161/onci.26663 DO - 10.4161/onci.26663 ID - Soriani2013 ER - TY - JOUR AU - Apetoh, L. AU - Mignot, G. AU - Panaretakis, T. AU - Kroemer, G. AU - Zitvogel, L. PY - 2008 DA - 2008// TI - Immunogenicity of anthracyclines: moving towards more personalized medicine JO - Trends Mol Med VL - 14 UR - https://doi.org/10.1016/j.molmed.2008.02.002 DO - 10.1016/j.molmed.2008.02.002 ID - Apetoh2008 ER - TY - JOUR AU - Grimwade, D. AU - Walker, H. AU - Harrison, G. AU - Oliver, F. AU - Chatters, S. AU - Harrison, C. J. AU - Wheatley, K. AU - Burnett, A. K. AU - Goldstone, A. H. PY - 2001 DA - 2001// TI - The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial JO - Blood VL - 98 UR - https://doi.org/10.1182/blood.V98.5.1312 DO - 10.1182/blood.V98.5.1312 ID - Grimwade2001 ER - TY - JOUR AU - Juliusson, G. AU - Billstrom, R. AU - Gruber, A. AU - Hellstrom-Lindberg, E. AU - Hoglunds, M. AU - Karlsson, K. AU - Stockelberg, D. AU - Wahlin, A. AU - Astrom, M. AU - Arnesson, C. PY - 2006 DA - 2006// TI - Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival JO - Leukemia VL - 20 UR - https://doi.org/10.1038/sj.leu.2404004 DO - 10.1038/sj.leu.2404004 ID - Juliusson2006 ER - TY - JOUR AU - Leith, C. P. AU - Kopecky, K. J. AU - Godwin, J. AU - McConnell, T. AU - Slovak, M. L. AU - Chen, I. M. AU - Head, D. R. AU - Appelbaum, F. R. AU - Willman, C. L. PY - 1997 DA - 1997// TI - Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A southwest oncology group study JO - Blood VL - 89 ID - Leith1997 ER - TY - JOUR AU - Cortes, J. E. AU - Goldberg, S. L. AU - Feldman, E. J. AU - Rizzeri, D. A. AU - Hogge, D. E. AU - Larson, M. AU - Pigneux, A. AU - Recher, C. AU - Schiller, G. AU - Warzocha, K. PY - 2015 DA - 2015// TI - Phase II, multicenter, randomized trial of CPX-351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML JO - Cancer VL - 121 UR - https://doi.org/10.1002/cncr.28974 DO - 10.1002/cncr.28974 ID - Cortes2015 ER - TY - JOUR AU - Fionda, C. AU - Soriani, A. AU - Zingoni, A. AU - Santoni, A. AU - Cippitelli, M. PY - 2015 DA - 2015// TI - NKG2D and DNAM-1 ligands: molecular targets for NK cell-mediated immunotherapeutic intervention in multiple myeloma JO - Biomed Res Int VL - 2015 UR - https://doi.org/10.1155/2015/178698 DO - 10.1155/2015/178698 ID - Fionda2015 ER - TY - JOUR AU - Morisaki, T. AU - Onishi, H. AU - Katano, M. PY - 2012 DA - 2012// TI - Cancer immunotherapy using NKG2D and DNAM-1 systems JO - Anticancer Res VL - 32 ID - Morisaki2012 ER -